MetaVia Inc. (MTVA)

NCM – Real vaqt narxi. Valyuta: USD

1.47

+0.05 (3.52%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

1.47

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:10 PM EDT

06.08.2026

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

All Active Patients Successfully Reached Highest Planned Dose Levels of 48 mg and 64 mg in Ongoing Phase 1 Part 3 Study of DA-1726 16-Week Topline Data Expected in the Fourth Quarter of 2026 CAMBRIDGE, Mass., Aug. 6, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate strategic update.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

MetaVia Inc. (MTVA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MetaVia Inc. (MTVA)

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

MetaVia Inc. (MTVA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MetaVia Inc. (MTVA)

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update